Betagenex is a preclinical CRO providing scientific expertise and drug discovery services in metabolic diseases to the pharmaceutical and biotech industries. Based on our expertise in diabetes, obesity, insulin secretion and pancreatic cell function, we offer a complete array of preclinical services for compound testing and target validation using state-of-the-art in vivo, in vitro and ex vivo approaches.